EP1982644A1 - Système analytique pour détecter une analyse dans un liquide du corps et perforation jetable intégrée et élément d'analyse - Google Patents

Système analytique pour détecter une analyse dans un liquide du corps et perforation jetable intégrée et élément d'analyse Download PDF

Info

Publication number
EP1982644A1
EP1982644A1 EP07008167A EP07008167A EP1982644A1 EP 1982644 A1 EP1982644 A1 EP 1982644A1 EP 07008167 A EP07008167 A EP 07008167A EP 07008167 A EP07008167 A EP 07008167A EP 1982644 A1 EP1982644 A1 EP 1982644A1
Authority
EP
European Patent Office
Prior art keywords
puncturing
test strip
sample application
analyzing
application area
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP07008167A
Other languages
German (de)
English (en)
Other versions
EP1982644B1 (fr
Inventor
Hans-Peter Haar
Joachim Hoenes
Carina Horn
Andreas Poredda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Original Assignee
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP11161430.1A priority Critical patent/EP2363062B1/fr
Application filed by F Hoffmann La Roche AG, Roche Diagnostics GmbH filed Critical F Hoffmann La Roche AG
Priority to ES07008167.4T priority patent/ES2568958T3/es
Priority to EP07008167.4A priority patent/EP1982644B1/fr
Priority to PL07008167.4T priority patent/PL1982644T3/pl
Priority to CN2008100933380A priority patent/CN101288592B/zh
Priority to US12/105,596 priority patent/US8328735B2/en
Publication of EP1982644A1 publication Critical patent/EP1982644A1/fr
Priority to HK09103515.1A priority patent/HK1125551A1/xx
Application granted granted Critical
Publication of EP1982644B1 publication Critical patent/EP1982644B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/157—Devices characterised by integrated means for measuring characteristics of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150015—Source of blood
    • A61B5/150022—Source of blood for capillary blood or interstitial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150358—Strips for collecting blood, e.g. absorbent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381—Design of piercing elements
    • A61B5/150442—Blade-like piercing elements, e.g. blades, cutters, knives, for cutting the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381—Design of piercing elements
    • A61B5/150503—Single-ended needles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150534—Design of protective means for piercing elements for preventing accidental needle sticks, e.g. shields, caps, protectors, axially extensible sleeves, pivotable protective sleeves
    • A61B5/150572—Pierceable protectors, e.g. shields, caps, sleeves or films, e.g. for hygienic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150534—Design of protective means for piercing elements for preventing accidental needle sticks, e.g. shields, caps, protectors, axially extensible sleeves, pivotable protective sleeves
    • A61B5/150694—Procedure for removing protection means at the time of piercing
    • A61B5/150717—Procedure for removing protection means at the time of piercing manually removed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101—Details
    • A61B5/15103—Piercing procedure
    • A61B5/15105—Purely manual piercing, i.e. the user pierces the skin without the assistance of any driving means or driving devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15142—Devices intended for single use, i.e. disposable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15186—Devices loaded with a single lancet, i.e. a single lancet with or without a casing is loaded into a reusable drive device and then discarded after use; drive devices reloadable for multiple use
    • A61B5/15188—Constructional features of reusable driving devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02—Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0295—Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157

Definitions

  • the present invention relates to an analytical system for detecting an analyte in a body fluid comprising a reusable analyzing instrument and a disposable integrated puncturing and analyzing element.
  • the integrated puncturing and analyzing element has a puncturing element with a tip for generating a puncture wound in a body part and an elongated flat test strip which comprises a top side and a bottom side.
  • the analyzing instrument has a housing, a holder for holding the integrated puncturing and analyzing element, and a coupling unit for coupling the puncturing element to a drive, said drive being adapted for driving a puncturing movement of the puncturing element during which a puncturing element is moved on a movement path, said puncturing movement including a forward phase in which the puncturing element is moved in a puncturing direction and a retraction phase during which the puncturing element is moved, after reaching a reversal point, opposite to the puncturing direction.
  • the puncturing element is arranged parallel to the test strip and is movable on its movement path relative to the test strip.
  • Puncturing instruments having lancets or puncturing elements are used for this purpose to generate a wound in a body part.
  • the puncturing systems are provided such that they can be used by the patient or a caregiver.
  • the body fluid After generating a puncture wound in the body part using the puncturing system, the body fluid must be applied to a test strip and transferred to an analytical system in a further step. Frequently, this will be a separate analytical system comprising an analyzing instrument and a disposable test strip. The analytical system is then used to detect the analyte of interest in the fluid.
  • two separate instruments are used according to the state of the art; one as a puncturing instrument for generating the puncture wound, the other as an analyzing instrument for analyzing the body fluid of the puncture wound.
  • the user thus has to operate two different instruments. After generating the puncture wound, he can mechanically squeeze the finger tip in order to increase the exit of blood from the finger. Only then does he touch the analyzing instrument to the puncture wound and take up a drop.
  • This handling is strongly preferred by some users since they have full control over the action involved in blood collection and diagnosis. They are the ones determining how to puncture and how much blood to squeeze from the wound. The user thus willingly accepts, on the one hand, that more blood exits from the wound than absolutely necessary for analysis, and, on the other hand, that the systems get more contaminated.
  • the users find it advantageous to perform action sequences they trained to do and are familiar with, while having control over the analysis required for diagnosis including the blood collection.
  • the two instruments, the puncturing instrument and the analyzing instrument can be relatively simple systems which can be manufactured cheaply since each instrument needs to perform exactly only one function.
  • An object of the present invention is therefore to propose an analytical system which, on the one hand, increases the operating convenience for the user and, on the other hand, allows the user to maintain full control over the individual steps of the procedure. Further, the instrument has to be cheap to manufacture.
  • the object is achieved by an analytical system with the features of claim 1 and by a disposable integrated puncturing and analyzing element with the features of claim 5.
  • Preferred embodiments of the system and/or puncturing and analyzing element are defined in the dependent subclaims.
  • the invention is also directed to a method with the features of claim 14.
  • the analytical system according to the invention for detecting an analyte in a body fluid comprises a disposable integrated puncturing and analyzing element which includes a puncturing element having a tip for generating a puncture wound in a body part and an elongated flat test strip with a top side and a bottom side, and a reusable analyzing instrument with a housing which includes a holder for holding an integrated puncturing and analyzing element, and a coupling unit for coupling a puncturing element to a drive.
  • the drive is adapted for driving a puncturing movement of the puncturing element.
  • the puncturing element is moved on a movement path in the puncturing direction during a forward phase and, after having reached a reversal point of the puncturing movement, the puncturing element is moved opposite to the puncturing direction in a retraction phase.
  • the puncturing element is arranged parallel to the test strip and movable relative to the test strip.
  • the integrated puncturing and analyzing element is held in the holder of the analyzing instrument such that, in a sample application position of the test strip, the top side of the test strip is facing upward.
  • the integrated puncturing and analyzing element is positioned in the holder and the drive is arranged such that, in a puncturing position of the test strip, the tip of the puncturing element is moved beyond front end of the test strip which is in the direction of insertion, in order to generate a puncture wound in a body part.
  • a sample application area for manual application of a drop from the puncture wound of the body part is provided on the top side of the test strip such that, in the sample application position, the drop is applied to the sample application area directly from above.
  • the housing of the analyzing instrument is shaped to allow access to the sample application area of a test strip positioned in the sample application position. Moreover, the housing is also shaped to allow access to the front end of a test strip which is positioned in the puncturing position.
  • the analyzing instrument has a puncturing location at which the tip of the puncturing element generates a puncture wound in the body part, and an sample application location at which a drop from a puncture wound is applied to the sample application area directly from above. Applying the drop directly from above to the sample application area is understand as to apply the drop from above to the area and without any intermediate steps or transfer steps in which the drop is transferred to the sample application area. It is not limited to an application perpendicular to the sample application area.
  • the sample application location is different from the puncturing location.
  • the puncturing direction of the puncturing element and the direction from which the drop is applied to the sample application area are essentially perpendicular to each other.
  • the sample application location and the puncturing location are located at the housing at a distance from each other.
  • the sample application location and the puncturing location can be arranged on different sides of the housing, for example on sides of the housing which are perpendicular to each other, wherein preferably the sample application location is on top and the puncturing location is in front of the housing.
  • the user positions his finger, which shall be representative of the body part hereinafter, at the puncturing location. Then, he carries out the puncturing movement of the puncturing element, whereby a puncture wound in the finger is generated. In a subsequent step, the user moves his finger from the puncturing location to the sample application location and applies the drop from the puncture wound to the sample application area directly from above. Since the puncturing location and the sample sample application location are spatially separated, the user needs to remove his finger from the instrument between the puncturing process and the analytical process. Between these two handling steps, i.e.
  • the user can, for example, squeeze his finger tip in order to increase the exit of blood from the puncture wound, if desired.
  • the user maintains full control over the proceedings of the analysis and can intervene at any time. He determines the individual proceedings and steps of action.
  • the front end of the dispo in the puncturing direction provides a skin reference and/or skin contact surface.
  • the finger Prior to puncturing with the puncturing element, the finger can be tautened using of the skin contact surface such that the user's sensation of pain upon puncturing is reduced.
  • the puncturing element which is being moved parallel to the test strip can be guided, for example, through the dispo such that the puncturing motion is linear and in a straight line. This has a positive influence on the user's sensation of pain.
  • the dispos are easy to store and keep in cartridges. The user has to store only one single consumable element, namely the dispo.
  • the puncturing location is preferably arranged at a recess or opening of the housing through which the front end of the test strip being in the puncturing position is accessible.
  • the user can either touch his finger directly to the opening or recess of the housing or to the front end of the test strip.
  • either the tip of the puncturing element moves through the recess and generates a puncture wound in the body part or the finger bulges through the recess into the inside of the housing.
  • the front end of the test strip extends through the recess of the housing.
  • the front end of the test strip can preferably form a skin contact surface which places the skin in tension.
  • the housing comprises a recess to allow access to the sample application area and to the front end of the test strip.
  • This so-called housing recess is sufficiently large for both the front end of the test strip and the sample application area being accessible to the user.
  • the housing can provide two openings or recesses, one for allowing access to the sample application area and one for allowing access to the front end of the test strip.
  • the opening in front of the front end of the test strip can be formed to fit to a finger tip.
  • the sample application position of the test strip and the puncturing position of the test strip are identical.
  • the dispo is held in the holder such that the test strip is both in the sample application position and in the puncturing position.
  • the dispo is held in its holder and preferably not moved between the generation of a puncture wound and the application of the sample. It is self-evident that it is feasible to move, for example, the entire holder within the housing between generating the puncture wound and applying the sample to the sample application area.
  • fixing the dispo in the holder is advantageous in that the dispo can be positioned very exactly, in particular in a case of photometric detecting of the analyte. The fixed dispo causes a very exact analyte detection which is associated with small permissible variation.
  • the position of the front end of the test strip is determined exactly.
  • the front end of the test strip in the puncturing direction provides a skin contact surface that forms a puncturing depth reference element.
  • a given puncturing depth value is determined by the distance in the puncturing direction between the skin contact surface and the position of the tip of the puncturing element at the reversal point of the puncturing movement.
  • the simultaneous tensioning in the finger tip skin caused by the skin contact surface leads to exact control of the puncturing depth. This has a positive effect on the sensation of pain during puncturing.
  • the sample application position is identical to the puncturing position.
  • This common position can simultaneously be identical to an analyzing position, in which the analysis of the fluid applied to the sample application area takes place.
  • the analyzing position can also be different from the other two positions.
  • the analyzing position is in such, that an analysis can be performed by means of a measuring and analyzing unit of the instrument.
  • the invention is not limited to a particular arrangement. It can in particular be used with analysis systems operating on the basis of photometric/optical principles, but it is also suitable for other systems such as electrochemical analysis systems.
  • the analysis position is such that a detection zone of the test strip (which can be identical with the sample application area but also can be different) is located at a location where it can be measured optically by an adjacent photometric device.
  • the analysis position has to be such that suitable electrical contact between electrodes of the test strip and an electrical measurement device of the instrument is possible.
  • Figure 1 shows an analytical system 1 according to the invention comprising an analyzing instrument 2 and a disposable integrated puncturing and analyzing element which is referred to as dispo 3.
  • the analyzing instrument 2 has a housing 4 with a top side 5.
  • a display facility 6 is arranged at the top side 5 for displaying the result of a detection of an analyte in a body fluid.
  • the analyzing instrument 2 comprises in its housing 4 a housing recess 7 through which the dispo 3 is at least partly accessible.
  • the housing recess 7 is designed to allow access to the front end of the dispo 3
  • the housing recess 7 extends from the top side 5 of the housing to a front side 10 of the housing 4.
  • the dispo 3 comprises a test strip 2 with a top side 13.
  • a test pad 12 and a sample application area 14 are arranged on the top side 13 of the test strip 2, wherein the sample application area 14 is located on the cover surface of the test pad 12.
  • the dispo 3 also comprises a puncturing element 15 having a tip 16, wherein the tip 16 of the puncturing element 15 can be moved beyond a front end 17 of the test strip 12 which is the end in the puncturing direction, in order to generate a puncture wound in a body part when the test strip 12 is arranged in the puncturing position ( Figures 1 and 2 ). In the puncturing position, the front end 17 of the test strip 12 is accessible through the housing recess 7. A user can place his fingertip on the front end 17 in order to generate a puncture wound in the fingertip.
  • the test strip 12 is arranged in a sample application position, in which the top side 13 of the test strip 12 is arranged such as to face upwards.
  • the top side 13 of the test strip 12 is parallel to the top side 5 of the housing 4.
  • the sample application area 14 is accessible through the housing recess 7 such that a drop exiting from the puncture wound can be applied to the sample application area 14 directly from above, i.e. it is moved from a direction perpendicular to the top side 5 or 13.
  • the sample application area 14 is suitable for direct manual application of a drop of a body fluid, in particular of blood.
  • Figure 2 shows part of a longitudinal section through the analyzing instrument 2 and the dispo 3 from Figure 1 .
  • the dispo 3 is held in a holder 18 of the analyzing instrument 2.
  • the holder 18 is provided in the form of holding pin 19 which engages through a bore hole 20 in the test strip 12 of the dispo 3.
  • the dispo 3 is additionally supported by an edge 21 at the front end of the housing recess 7 such that the dispos 3 is arranged and positioned on the edge 21.
  • An edge part 22 of the housing recess 7 presses from above against the top side 13 of the test strip 12 such that the dispo 3 is fixed in its position in the analyzing instrument 2.
  • a coupling unit 23 comprises a coupling element 24 for coupling to the puncturing element 15.
  • the coupling element 24 is provided in the form of a drive side coupling structure 25 which engages an element side coupling structure 26 on the puncturing element 15 in a fitting fashion.
  • the drive side coupling structure 25 and the matching element side coupling structure 26 can be of any shape that allows force transmission from a drive of the analyzing instrument 2 to the puncturing element 15.
  • the coupling element 24 engages the puncturing element 15 from below such that the puncturing element 15 is coupled to a drive (not shown) for driving a puncturing movement of the puncturing element 15.
  • a measuring and analyzing unit 27 is arranged within the analyzing instrument 2 such that the sample application area 14 of the dispo 3 is positioned above the measuring and analyzing unit 27 when the test strip 12 is located in the sample application position.
  • the measuring and analyzing unit 27 is a photometric unit. A photometrically detectable change occurs as a consequence of a reaction of a sample of a body fluid, which is contacted to the test pad 11, and a reagent contained in the test pad 11. This change is measured by the photometric unit.
  • the sample application area 14 is a part of the test pad 11 (namely its upper side).
  • the photometric detection preferably takes place at a detection zone 11 a of the test field located at its bottom side ( Figure 2 ).
  • the sample application area can be provided at a certain distance from the section of the test strip where the detection zone is located.
  • the fluid sample can be transferred from the sample application area 14 to the respective reagent and detection zones by means of a capillary channel.
  • test strip may be an electrochemical biosensor in which case an electrochemical measuring and analyzing unit is suitably integrated into the analyzing instrument 2.
  • Figures 3 to 5 show various embodiments of a disposable integrated puncturing and analyzing element, dispo 3.
  • the test strip 12 of the dispo 3 comprises on its back end in the puncturing direction a recess, which the holder of the analyzing instrument 2 can engage.
  • the recess can be provided in the form of a bore hole 20, it can take any shape, but preferably it is round.
  • a holding structure can be provided to which a holder is engaged in order to fix the dispo 3 in its position in the analyzing instrument 2.
  • a protective film 28, for example a strip-off cover tape, comprises a protruding edge 39 for grasping by the user and a barrier 29.
  • the film 28 is arranged at the front end 17 of the test strip 12 such that the barrier 29 touches on a front face 30 at the front end 17 of the test strip 12.
  • the front face 30 is a skin contact surface 30a to which the user touches his finger.
  • the skin contact surface 30a can be arranged and serve as puncturing depth reference element.
  • the protective film 28 is part of a sterile protective sheath 31 which includes an upper cover film 32 and a lower cover film 33.
  • a tape-like material or a foil i.e. a plastic foil, can be used as a sheath.
  • the sterile protective sheath 31 serves for sealing the puncturing element 15.
  • the sterile protective sheath 31 is a primary packaging element of the dispo 3.
  • the puncturing element 15 packaged in the sterile protective sheath 31 can be sterilized after sealing and then remains sterile for the entire time of storage of the dispo.
  • the test strip 12 comprises a recess 34 in its front part.
  • the puncturing element 15 is arranged in this preferred recess 34.
  • the recess 34 is open towards the front end 17 of the test strip 12 such that the tip 16 of the puncturing element 15 can exit through a front orifice 35 of the recess 34 on its puncturing path and generate a puncture wound in a body part being in contact to the orifice 35.
  • the orifice 35 is closed-off by the barrier 29 of the protective film 28.
  • the protective film 28 with the barrier 29 is manually removed by a user by pulling the protective film 28 from the dispo 3 in the puncturing direction.
  • a recess and/or orifice 36 in the cover film 33 is also opened such that a coupling element 24 which is provided as a drive side coupling structure 25 for engaging with the puncturing element 15.
  • the puncturing element 15 has a matching element side coupling structure 26 which is arranged as a coupling recess 37 for mutual coupling with the drive side coupling structure 25.
  • the drive side coupling structure 25 extends through the orifice 36 of the lower cover film 33 into the coupling recess 37.
  • the puncturing element 15 is then being coupled to the coupling element 24 such that the drive connected to the coupling element 24 can transmit force to the puncturing element 15 and drive it on its movement path.
  • the recess 36 in the lower cover film 33 must be adapted and arranged such that the drive side coupling structure 25 extending through it is not impeded when driving the puncturing element 15 on this path of movement.
  • the use of the dispo 3 according to Figure 3 involves that the dispo 3 is first inserted into the analyzing instrument 2 and locked in place in the holder 18. Then the user pulls out the protective film 28 by its protruding edge 39 towards the front, whereby the barrier 29 is removed and the orifice 35 is released. Simultaneously, the engagement for the coupling unit 23 in the test element 15 is released. In the next step, the user presses his finger to the face 30 of the dispo 3, like in conventional puncturing instruments against the cap with an exit opening for the puncturing element. After the puncture, the user removes his finger from the analyzing instrument 2 and applies the puncture wound to the sample application area 14 of the dispo 3 from above such that a drop is transferred from the wound to the sample application area 14.
  • the puncturing element 15 is surrounded by spacers 38 at least on its longitudinal sides with the thickness of the spacers being at least equal to the thickness of the puncturing element 15. Thickness is defined as the dimension perpendicular to the top side 13 of the test strip 12. If the thickness of the spacers 38 exceeds the thickness of the puncturing element 15 just a little, the puncturing element 15 can be clamped between the upper cover film 32 and the lower cover film 33 such that any independent movement is precluded. Using this so-called mild snap-in structure, the puncturing element 15 is snapped in place inside the sterile protective sheath 31 such that it cannot unintendedly move forward and damage the sterile protective sheath 31 during storage and transport of the dispo 3.
  • the snap-in structure prevents the spent, contaminated tip 16 of the puncturing element 15 from penetrating the orifice 35.
  • the clamping pressure is not allowed to extend a predetermined pressure value to prevent any influence of the puncturing movement of the puncturing element 15.
  • the Figures 4a,b show an alternative embodiment of the dispo 3.
  • the protective film 28 does not comprise a protruding edge 39, but rather ends at barrier 29.
  • Barrier 29 is adapted and arranged such that it can be perforated by the puncturing element 15 on its path of movement. Therefore, the dispo is ready for use right away and the user need not first remove the protective film 28 by pulling it out.
  • the drive side coupling structure 25 of the coupling element 24 is adapted and arranged such that the protective film 28 of the sterile protective sheath 31 is cut upon engagement through the orifice 36 of the lower cover film 33 into the element side coupling structure 26 of the puncturing element 15.
  • the drive side coupling structure 25 comprises two sharp, knife-like pins 40 which cut the protective film 28.
  • the sterile protective sheath 31 is preferably adapted in such a manner that the protective film 28 tears easily and continues to tear easily.
  • the sample application area 14 is arranged behind the puncturing element 15 in the puncturing direction.
  • the sample application area 14 is located at a distance from the puncturing element 15 in both embodiments.
  • an embodiment, in which the puncturing element 15 can protrude or extend at least partly under the sample application area 14 is also conceivable.
  • the analysis of the fluid applied to the sample application area 14 must be feasible in the analyzing position of the test strip 12.
  • the puncturing element 15 covers the sample application area 14.
  • a lower guiding part 41, in which the puncturing element 15 is guided, is arranged on the top side 13 of the test strip 12 between the sample application area 14 and the front end 17 of the test strip 12.
  • the thickness (dimension perpendicular to the top side 13) of the guiding part 41 is equal or larger by the thickness of the puncturing element 15 than the thickness of the test pad 11.
  • the tip 16 of the puncturing element 15 is moved in a guiding channel 42 which comprises an orifice 35 on its front end.
  • the guiding channel 42 is formed by two spacers 38 whose thickness is at least equal to the thickness of the puncturing element 15.
  • the guiding part 41 comprises a guiding pin 43 which extends through a guiding recess 44 in the puncturing element 15.
  • the part of the puncturing element 15 which faces away from the tip 16 and is called cover part 45, is wider than the test pad 11 and the sample application area 14. Width is defined as the dimension transverse to the puncturing direction and transverse to the thickness.
  • the width of the cover part 45 can be sufficiently large, if applicable, to also cover parts of the analyzing instrument 2 and protect them from getting contaminated by blood.
  • the cover part 45 of the puncturing element 15 comprises a transfer recess 46 which is called release hole or transfer orifice.
  • the transfer recess 46 is round, but it can be of any shape. It is arranged on the puncturing element 15 such that it is positioned above the sample application area 14 when the puncturing element 15 is positioned in a home position. In this position, the puncturing element 15 is retracted fully into the dispo 3 such that its tip 16 is arranged within the guiding channel 42, Figure 5b . The puncturing element is at least at the end of the puncturing movement, i.e. after performing the puncture wound in the home position. The sample application area 14 is then accessible via the transfer recess 46.
  • the transfer recess 46 can be designed relatively small, i.e. clearly smaller than the width of the sample application area 14.
  • the transfer recess 46 can be used as a so-called aiming aid which ensures that the blood is positioned in the middle of the sample application area 14 when applying small drops of blood.
  • this arrangement allows even very small amounts of blood (less than one microliter) to be analyzed reliably.
  • the sterile protective sheath 31 is formed by the sterile lower guiding part 41, the upper cover film 32, and the barrier 29.
  • the barrier 29 is perforated by the tip 16 of the puncturing element 15 proceeding on the path of movement.
  • the barrier 29 is sufficiently high (dimension perpendicular to the top side 13) for it to cover the face 30 of the test strip 12, the front end of the lower guiding part 41 and the face of the upper cover film 32.
  • the puncturing element 15 is partly sealed by a sterile protective sheath 31 such that at least the tip 16 is maintained in sterile condition.
  • the puncturing element 15 comprises at its back end 47 in the puncturing direction an element side coupling structure 26 which can be engaged from above by the coupling element 24 of the coupling unit.
  • the coupling unit 23 in the analyzing instrument 2 can be arranged above the dispo 3. It is advantageous in this embodiment that the front part of the dispo which is between the sample application area 14 and the front end 17 can be relatively short. This allows for the implementation of small dispos 3.
  • Another advantage of this embodiment of the dispo 3 is that a partial coverage of the sample application area 14 by the puncturing element 15 provides a hygienic function which prevents contamination of the instrument.
  • the puncturing element 15, the guiding part 41, the spacers 38, the upper film cover 32 and the barrier 29 may be manufactured as a sterile subassembly and joined to the non-sterile test strip as a final assembly operation. This allows use of analytical chemistry in the test pad 11 that is not compatible with sterilization processes, while maintaining the sterility of the portions of the dispo 3 that contact the patient.
  • FIGS. 5b and 5c show the dispo 3 with partly sectioned upper cover film 32.
  • Figure 5b shows the test strip in the sample application position.
  • the transfer orifice 46 is positioned directly above the sample application area 14.
  • the tip 16 of the puncturing element 15 is fully retracted into the dispo 3.
  • the guiding pin 43 of the lower guiding part 41 is arranged at the front end of the guiding recess 44.
  • Figure 5c shows the arrangement of the dispo 3 if the puncturing element 15 is moved in the direction of the front end 17 of the test strip 12 such that the tip 16 protrudes fully from the dispo 3.
  • the guiding pin 43 of the lower guiding part 41 is now arranged at the back end of the guiding recess 44 of the puncturing element 15 and limits the movement path of the puncturing element 15. This position corresponds to the reversal point of the puncturing movement.
  • the sample application area 14 is now covered by the back end 47 of the puncturing element 15.
  • the puncturing element 15 such that the transfer recess 46 of the puncturing element 15 is arranged above the sample application area 14 only if the test strip 12 is located in the sample application position. In a home position, the transfer recess 46 could be positioned such that the sample application area 14 is concealed by the test strip 12.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Optics & Photonics (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
EP07008167.4A 2007-04-21 2007-04-21 Système analytique pour détecter une analyte dans un liquide du corps et perforation jetable intégrée et élément d'analyse Active EP1982644B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
ES07008167.4T ES2568958T3 (es) 2007-04-21 2007-04-21 Sistema analítico para detectar un analito en un fluido corporal y elemento de punción y análisis integrado desechable
EP07008167.4A EP1982644B1 (fr) 2007-04-21 2007-04-21 Système analytique pour détecter une analyte dans un liquide du corps et perforation jetable intégrée et élément d'analyse
PL07008167.4T PL1982644T3 (pl) 2007-04-21 2007-04-21 System analityczny do wykrywania analitu w płynie ustrojowym i zintegrowany element jednorazowego użytku do nakłucia i analizy
EP11161430.1A EP2363062B1 (fr) 2007-04-21 2007-04-21 Système analytique pour détecter une analyse dans un liquide du corps
CN2008100933380A CN101288592B (zh) 2007-04-21 2008-04-18 检测体液分析物的分析***和一次性整合穿刺和分析元件
US12/105,596 US8328735B2 (en) 2007-04-21 2008-04-18 Analytical system for detecting an analyte in a body fluid and disposable integrated puncturing and analyzing element
HK09103515.1A HK1125551A1 (en) 2007-04-21 2009-04-16 Analytical system for detecting an analyte in a body fluid and disposable integrated puncturing and analyzing element

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07008167.4A EP1982644B1 (fr) 2007-04-21 2007-04-21 Système analytique pour détecter une analyte dans un liquide du corps et perforation jetable intégrée et élément d'analyse

Related Child Applications (2)

Application Number Title Priority Date Filing Date
EP11161430.1A Division-Into EP2363062B1 (fr) 2007-04-21 2007-04-21 Système analytique pour détecter une analyse dans un liquide du corps
EP11161430.1A Division EP2363062B1 (fr) 2007-04-21 2007-04-21 Système analytique pour détecter une analyse dans un liquide du corps

Publications (2)

Publication Number Publication Date
EP1982644A1 true EP1982644A1 (fr) 2008-10-22
EP1982644B1 EP1982644B1 (fr) 2016-03-09

Family

ID=38512417

Family Applications (2)

Application Number Title Priority Date Filing Date
EP11161430.1A Not-in-force EP2363062B1 (fr) 2007-04-21 2007-04-21 Système analytique pour détecter une analyse dans un liquide du corps
EP07008167.4A Active EP1982644B1 (fr) 2007-04-21 2007-04-21 Système analytique pour détecter une analyte dans un liquide du corps et perforation jetable intégrée et élément d'analyse

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP11161430.1A Not-in-force EP2363062B1 (fr) 2007-04-21 2007-04-21 Système analytique pour détecter une analyse dans un liquide du corps

Country Status (6)

Country Link
US (1) US8328735B2 (fr)
EP (2) EP2363062B1 (fr)
CN (1) CN101288592B (fr)
ES (1) ES2568958T3 (fr)
HK (1) HK1125551A1 (fr)
PL (1) PL1982644T3 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7885697B2 (en) 2004-07-13 2011-02-08 Dexcom, Inc. Transcutaneous analyte sensor
US8229535B2 (en) 2008-02-21 2012-07-24 Dexcom, Inc. Systems and methods for blood glucose monitoring and alert delivery
US8636672B2 (en) 2007-02-28 2014-01-28 Nipro Diagnostics, Inc. Test strip with integrated lancet
US9986942B2 (en) 2004-07-13 2018-06-05 Dexcom, Inc. Analyte sensor
US10610136B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10813577B2 (en) 2005-06-21 2020-10-27 Dexcom, Inc. Analyte sensor

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7322942B2 (en) * 2004-05-07 2008-01-29 Roche Diagnostics Operations, Inc. Integrated disposable for automatic or manual blood dosing
WO2006107914A2 (fr) * 2005-04-04 2006-10-12 Facet Technologies, Llc Dispositif de lancette a profil etroit
US8475732B2 (en) 2010-10-26 2013-07-02 Abbott Diabetes Care Inc. Analyte measurement devices and systems, and components and methods related thereto
US9874573B2 (en) 2008-10-02 2018-01-23 Gaia Medical Institute Health test for a broad spectrum of health problems
WO2011006913A1 (fr) * 2009-07-14 2011-01-20 Roche Diagnostics Gmbh Bande à lancettes optimisée
US9713440B2 (en) 2010-12-08 2017-07-25 Abbott Diabetes Care Inc. Modular analyte measurement systems, modular components thereof and related methods
USD680454S1 (en) * 2011-10-25 2013-04-23 Abbott Diabetes Care Inc. Analyte meter and strip port
US9408568B2 (en) 2013-04-15 2016-08-09 Becton, Dickinson And Company Biological fluid sampling device
CA3005826C (fr) 2013-04-15 2021-11-23 Becton, Dickinson And Company Dispositif de collecte de fluide biologique et separation de fluide biologique et systeme d'essai
WO2015078832A1 (fr) 2013-11-27 2015-06-04 Roche Diagnostics Gmbh Éjecteur de bandelette réactive de poignée
USD757273S1 (en) * 2015-03-04 2016-05-24 Cilag Gmbh International Analyte meter design
EP3340880A1 (fr) * 2015-08-28 2018-07-04 POPS! Diabetes Care, Inc. Système de gestion de la glycémie
JP1627346S (fr) * 2018-05-31 2019-03-25

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1174083A2 (fr) * 2000-07-10 2002-01-23 Bayer Corporation Lance mince pour capteur de test
EP1189064A1 (fr) * 2000-09-01 2002-03-20 Roche Diagnostics GmbH Méthode pour vérifier l'utilisabilité d'éléments d'essai
EP1402812A1 (fr) * 2002-09-30 2004-03-31 Becton, Dickinson and Company Détecteur de fluide avec lancette intégrée
EP1466558A2 (fr) * 2001-08-29 2004-10-13 Roche Diagnostics GmbH Procédé de fabrication d'un moyen d'analyse avec lancette et élément d'essai
WO2005006985A2 (fr) 2003-07-16 2005-01-27 F. Hoffann-La Roche Ag Appareil d'analyse et procede d'analyse de liquides organiques
WO2005102154A2 (fr) * 2004-04-16 2005-11-03 Becton, Dickinson And Company Glucometre sanguin comprenant un dispositif a lancette monobloc et un flacon de stockage de bande d'analyse utilisable d'une seule main et ses procedes d'utilisation
WO2006092281A2 (fr) 2005-03-02 2006-09-08 Roche Diagnostics Gmbh Bandelette reactive dynamique a lancette integree avec cache de sterilite

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4627445A (en) 1985-04-08 1986-12-09 Garid, Inc. Glucose medical monitoring system
US4873993A (en) 1986-07-22 1989-10-17 Personal Diagnostics, Inc. Cuvette
US5951492A (en) 1996-05-17 1999-09-14 Mercury Diagnostics, Inc. Methods and apparatus for sampling and analyzing body fluid
ATE227844T1 (de) 1997-02-06 2002-11-15 Therasense Inc Kleinvolumiger sensor zur in-vitro bestimmung
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US5871494A (en) 1997-12-04 1999-02-16 Hewlett-Packard Company Reproducible lancing for sampling blood
US6338790B1 (en) 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US7410468B2 (en) * 2002-04-19 2008-08-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US20040127818A1 (en) 2002-12-27 2004-07-01 Roe Steven N. Precision depth control lancing tip
US7083526B2 (en) * 2004-01-28 2006-08-01 Timothy Durnin Golf putter
WO2005104949A1 (fr) 2004-04-15 2005-11-10 Roche Diagnostics Gmbh Dispositif de monitorage localise integré avec capteur de fluide
US7322942B2 (en) 2004-05-07 2008-01-29 Roche Diagnostics Operations, Inc. Integrated disposable for automatic or manual blood dosing
US7727166B2 (en) * 2004-07-26 2010-06-01 Nova Biomedical Corporation Lancet, lancet assembly and lancet-sensor combination
US7488298B2 (en) 2004-10-08 2009-02-10 Roche Diagnostics Operations, Inc. Integrated lancing test strip with capillary transfer sheet
US7695442B2 (en) * 2005-04-12 2010-04-13 Roche Diagnostics Operations, Inc. Integrated lancing test strip with retractable lancet

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1174083A2 (fr) * 2000-07-10 2002-01-23 Bayer Corporation Lance mince pour capteur de test
EP1189064A1 (fr) * 2000-09-01 2002-03-20 Roche Diagnostics GmbH Méthode pour vérifier l'utilisabilité d'éléments d'essai
EP1466558A2 (fr) * 2001-08-29 2004-10-13 Roche Diagnostics GmbH Procédé de fabrication d'un moyen d'analyse avec lancette et élément d'essai
EP1402812A1 (fr) * 2002-09-30 2004-03-31 Becton, Dickinson and Company Détecteur de fluide avec lancette intégrée
WO2005006985A2 (fr) 2003-07-16 2005-01-27 F. Hoffann-La Roche Ag Appareil d'analyse et procede d'analyse de liquides organiques
WO2005102154A2 (fr) * 2004-04-16 2005-11-03 Becton, Dickinson And Company Glucometre sanguin comprenant un dispositif a lancette monobloc et un flacon de stockage de bande d'analyse utilisable d'une seule main et ses procedes d'utilisation
WO2006092281A2 (fr) 2005-03-02 2006-09-08 Roche Diagnostics Gmbh Bandelette reactive dynamique a lancette integree avec cache de sterilite

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10932700B2 (en) 2004-07-13 2021-03-02 Dexcom, Inc. Analyte sensor
US10827956B2 (en) 2004-07-13 2020-11-10 Dexcom, Inc. Analyte sensor
US11883164B2 (en) 2004-07-13 2024-01-30 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US11064917B2 (en) 2004-07-13 2021-07-20 Dexcom, Inc. Analyte sensor
US8792953B2 (en) 2004-07-13 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US11045120B2 (en) 2004-07-13 2021-06-29 Dexcom, Inc. Analyte sensor
US11026605B1 (en) 2004-07-13 2021-06-08 Dexcom, Inc. Analyte sensor
US9986942B2 (en) 2004-07-13 2018-06-05 Dexcom, Inc. Analyte sensor
US10524703B2 (en) 2004-07-13 2020-01-07 Dexcom, Inc. Transcutaneous analyte sensor
US10993641B2 (en) 2004-07-13 2021-05-04 Dexcom, Inc. Analyte sensor
US10799159B2 (en) 2004-07-13 2020-10-13 Dexcom, Inc. Analyte sensor
US10993642B2 (en) 2004-07-13 2021-05-04 Dexcom, Inc. Analyte sensor
US10813576B2 (en) 2004-07-13 2020-10-27 Dexcom, Inc. Analyte sensor
US10709362B2 (en) 2004-07-13 2020-07-14 Dexcom, Inc. Analyte sensor
US10709363B2 (en) 2004-07-13 2020-07-14 Dexcom, Inc. Analyte sensor
US10980452B2 (en) 2004-07-13 2021-04-20 Dexcom, Inc. Analyte sensor
US7885697B2 (en) 2004-07-13 2011-02-08 Dexcom, Inc. Transcutaneous analyte sensor
US10722152B2 (en) 2004-07-13 2020-07-28 Dexcom, Inc. Analyte sensor
US10918313B2 (en) 2004-07-13 2021-02-16 Dexcom, Inc. Analyte sensor
US10799158B2 (en) 2004-07-13 2020-10-13 Dexcom, Inc. Analyte sensor
US10918314B2 (en) 2004-07-13 2021-02-16 Dexcom, Inc. Analyte sensor
US10918315B2 (en) 2004-07-13 2021-02-16 Dexcom, Inc. Analyte sensor
US10918317B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10716498B2 (en) 2005-03-10 2020-07-21 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10856787B2 (en) 2005-03-10 2020-12-08 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10898114B2 (en) 2005-03-10 2021-01-26 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US11051726B2 (en) 2005-03-10 2021-07-06 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10918316B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610135B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10743801B2 (en) 2005-03-10 2020-08-18 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10918318B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US11000213B2 (en) 2005-03-10 2021-05-11 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10925524B2 (en) 2005-03-10 2021-02-23 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10617336B2 (en) 2005-03-10 2020-04-14 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10709364B2 (en) 2005-03-10 2020-07-14 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610137B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610136B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10813577B2 (en) 2005-06-21 2020-10-27 Dexcom, Inc. Analyte sensor
US8636672B2 (en) 2007-02-28 2014-01-28 Nipro Diagnostics, Inc. Test strip with integrated lancet
US8229535B2 (en) 2008-02-21 2012-07-24 Dexcom, Inc. Systems and methods for blood glucose monitoring and alert delivery
US9143569B2 (en) 2008-02-21 2015-09-22 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US9020572B2 (en) 2008-02-21 2015-04-28 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US11102306B2 (en) 2008-02-21 2021-08-24 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US8591455B2 (en) 2008-02-21 2013-11-26 Dexcom, Inc. Systems and methods for customizing delivery of sensor data

Also Published As

Publication number Publication date
HK1125551A1 (en) 2009-08-14
US8328735B2 (en) 2012-12-11
EP1982644B1 (fr) 2016-03-09
EP2363062A1 (fr) 2011-09-07
US20080262386A1 (en) 2008-10-23
ES2568958T3 (es) 2016-05-05
PL1982644T3 (pl) 2016-09-30
CN101288592B (zh) 2011-06-22
CN101288592A (zh) 2008-10-22
EP2363062B1 (fr) 2017-11-22

Similar Documents

Publication Publication Date Title
EP2363062B1 (fr) Système analytique pour détecter une analyse dans un liquide du corps
US7771367B2 (en) Lancet wheel
US7396334B2 (en) Analytical device with lancet and test element
JP4468324B2 (ja) 分析補助手段
RU2343833C2 (ru) Интегральный измеритель для исследования образцов
US7470238B2 (en) Unit for piercing, and piercing device
JP4383090B2 (ja) 検体検出システムおよび検体の濃度を検査する方法
US6036924A (en) Cassette of lancet cartridges for sampling blood
JP4647898B2 (ja) 体液試料捕捉試験装置およびカートリッジ
US20050004494A1 (en) Lancet device having capillary action
US9138179B2 (en) Flexible lancet
EP1611842A1 (fr) Appareil pour la fabrication de dispositifs médicaux
EP1611849A1 (fr) Méthode permettant la production de biocapteurs intégrés
US20050101981A1 (en) Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge
KR101175967B1 (ko) 체액 내의 분석물을 판정하기 위한 분석 시스템 및 일회용 통합형 샘플 획득 및 분석 요소
US8172866B2 (en) Medical aid

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

17P Request for examination filed

Effective date: 20090327

17Q First examination report despatched

Effective date: 20090423

AKX Designation fees paid

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602007045085

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A61B0005000000

Ipc: A61B0005150000

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 5/15 20060101AFI20150714BHEP

Ipc: A61B 5/151 20060101ALI20150714BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: F. HOFFMANN-LA ROCHE AG

Owner name: ROCHE DIAGNOSTICS GMBH

INTG Intention to grant announced

Effective date: 20150908

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 778875

Country of ref document: AT

Kind code of ref document: T

Effective date: 20160315

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602007045085

Country of ref document: DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2568958

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20160505

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160309

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160610

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 778875

Country of ref document: AT

Kind code of ref document: T

Effective date: 20160309

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160309

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160309

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160309

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160709

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160309

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160309

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160309

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160309

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160711

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160309

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602007045085

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160309

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160430

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160309

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160430

26N No opposition filed

Effective date: 20161212

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160609

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160309

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160421

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160421

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160421

PGRI Patent reinstated in contracting state [announced from national office to epo]

Ref country code: IT

Effective date: 20170710

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 12

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20070421

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160309

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160309

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160430

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160421

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160309

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20210324

Year of fee payment: 15

Ref country code: NL

Payment date: 20210322

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20210331

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20210318

Year of fee payment: 15

Ref country code: IT

Payment date: 20210416

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PL

Payment date: 20210407

Year of fee payment: 15

Ref country code: ES

Payment date: 20210505

Year of fee payment: 15

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602007045085

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20220501

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20220421

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220501

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220421

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220430

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20221103

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20230530

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220421

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220422